Jupiter Asset Management Ltd. Purchases 629,518 Shares of CVS Health Corporation $CVS

Jupiter Asset Management Ltd. boosted its holdings in shares of CVS Health Corporation (NYSE:CVS) by 578.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 738,418 shares of the pharmacy operator’s stock after buying an additional 629,518 shares during the quarter. Jupiter Asset Management Ltd. owned approximately 0.06% of CVS Health worth $55,669,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Avion Wealth grew its holdings in shares of CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 189 shares during the last quarter. Harbor Capital Advisors Inc. increased its holdings in shares of CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 142 shares in the last quarter. Corundum Trust Company INC acquired a new position in shares of CVS Health in the third quarter worth about $29,000. Front Row Advisors LLC boosted its position in CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 371 shares in the last quarter. Finally, Twin Peaks Wealth Advisors LLC purchased a new position in shares of CVS Health during the 2nd quarter valued at approximately $36,000. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Performance

Shares of CVS stock opened at $77.35 on Friday. The stock’s 50-day moving average price is $78.58 and its 200 day moving average price is $76.57. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The stock has a market capitalization of $98.40 billion, a PE ratio of 56.05, a price-to-earnings-growth ratio of 0.81 and a beta of 0.50. CVS Health Corporation has a 52-week low of $58.35 and a 52-week high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. During the same quarter in the prior year, the business earned $1.19 earnings per share. The company’s quarterly revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, equities research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.4%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s dividend payout ratio is currently 192.75%.

Wall Street Analysts Forecast Growth

Several analysts recently commented on CVS shares. Barclays boosted their price target on CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 10th. Robert W. Baird raised their target price on CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th. Piper Sandler restated an “overweight” rating and set a $101.00 price target (up from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. Mizuho upped their target price on shares of CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th. Finally, Bank of America reduced their price objective on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a report on Tuesday, January 27th. Nineteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $94.91.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.